Functional and pathological roles of the 12- and 15-lipoxygenases

Progress in Lipid Research

Volumn 50, Issue 1, 2011, Pages 115-131

  Dobrian, Anca D ^a   Lieb, David C ^a   Cole, Banumathi K ^a   Taylor Fishwick, David A ^a   Chakrabarti, Swarup K ^a   Nadler, Jerry L ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

12 15 Lipoxygenase; Adipose tissue; Arachidonic acid; Atherosclerosis; Inflammation; Kidney; Obesity; Pancreatic islet

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; FATTY ACID;

ADIPOSE TISSUE; ALZHEIMER DISEASE; ANGIOGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHRONIC INFLAMMATION; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE MODEL; ENZYME ACTIVITY; GENE DELETION; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY FUNCTION; METABOLITE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET; PARKINSON DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ADIPOSE TISSUE; ANIMALS; ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 15-LIPOXYGENASE; BLOOD VESSELS; DISEASE; HUMANS; KIDNEY;

ANIMALIA;

EID: 78650698895     PISSN: 01637827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plipres.2010.10.005     Document Type: Review

References (232)

1. A.P. Simopoulos Human requirement for N-3 polyunsaturated fatty acids Poult Sci 79 2000 961 970
2. M. Williams, and J. Nadler Lipoxygenase products. Hypertension primer: the essentials of high blood pressure: basic science, population science, and clinical management 4th ed. 2007 Lippincott Williams & Wilkins Philadelphia
3. S. Canals, M.J. Casarejos, S. de Bernardo, E. Rodriguez-Martin, and M.A. Mena Nitric oxide triggers the toxicity due to glutathione depletion in midbrain cultures through 12-lipoxygenase J Biol Chem 278 2003 21542 21549
4. D. Pratico, V. Zhukareva, Y. Yao, K. Uryu, C.D. Funk, and J.A. Lawson 12/15-lipoxygenase is increased in Alzheimer's disease: possible involvement in brain oxidative stress Am J Pathol 164 2004 1655 1662
5. G. Lambeau, and M.H. Gelb Biochemistry and physiology of mammalian secreted phospholipases A2 Ann Rev Biochem 77 2008 495 520
6. R. Natarajan, and J.L. Nadler Lipid inflammatory mediators in diabetic vascular disease Arterioscler Thromb Vasc Biol 24 2004 1542 1548
7. A.R. Brash Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate J Biol Chem 274 1999 23679 23682
8. C.D. Funk Prostaglandins and leukotrienes: advances in eicosanoid biology Science 294 2001 1871 1875
9. X.S. Chen, and C.D. Funk Structure-function properties of human platelet 12-lipoxygenase: chimeric enzyme and in vitro mutagenesis studies Faseb J 7 1993 694 701
10. H. Kuhn, M. Walther, and R.J. Kuban Mammalian arachidonate 15-lipoxygenases structure, function, and biological implications Prostaglandins Other Lipid Mediat 68-69 2002 263 290
11. X.S. Chen, U. Kurre, N.A. Jenkins, N.G. Copeland, and C.D. Funk CDNA cloning, expression, mutagenesis of C-terminal isoleucine, genomic structure, and chromosomal localizations of murine 12-lipoxygenases J Biol Chem 269 1994 13979 13987
12. M. Berger, K. Schwarz, H. Thiele, I. Reimann, A. Huth, and S. Borngraber Simultaneous expression of leukocyte-type 12-lipoxygenase and reticulocyte-type 15-lipoxygenase in rabbits J Mol Biol 278 1998 935 948
13. H. Kuhn, P. Chaitidis, J. Roffeis, and M. Walther Arachidonic acid metabolites in the cardiovascular system: the role of lipoxygenase isoforms in atherogenesis with particular emphasis on vascular remodeling J Cardiovasc Pharmacol 50 2007 609 620
14. I. Shureiqi, and S.M. Lippman Lipoxygenase modulation to reverse carcinogenesis Cancer Res 61 2001 6307 6312
15. C. Sultana, Y. Shen, V. Rattan, and V.K. Kalra Lipoxygenase metabolites induced expression of adhesion molecules and transendothelial migration of monocyte-like HL-60 cells is linked to protein kinase C activation J Cell Physiol 167 1996 477 487
16. R. Natarajan, M.A. Reddy, K.U. Malik, S. Fatima, and B.V. Khan Signaling mechanisms of nuclear factor-kappab-mediated activation of inflammatory genes by 13-hydroperoxyoctadecadienoic acid in cultured vascular smooth muscle cells Arterioscler Thromb Vasc Biol 21 2001 1408 1413
17. M.A. Reddy, P.R. Thimmalapura, L. Lanting, J.L. Nadler, S. Fatima, and R. Natarajan The oxidized lipid and lipoxygenase product 12(S)- hydroxyeicosatetraenoic acid induces hypertrophy and fibronectin transcription in vascular smooth muscle cells via p38 MAPK and cAMP response element-binding protein activation. Mediation of angiotensin II effects J Biol Chem 277 2002 9920 9928
18. P. Maderna, and C. Godson Lipoxins: resolutionary road Br J Pharmacol 158 2009 947 959
19. B.D. Levy Resolvins and protectins: natural pharmacophores for resolution biology Prostaglandins Leukot Essent Fatty Acids 82 2010 327 332
20. J. Wittwer, and M. Hersberger The two faces of the 15-lipoxygenase in atherosclerosis Prostaglandins Leukot Essent Fatty Acids 77 2007 67 77
21. B.D. Levy, P. Kohli, K. Gotlinger, O. Haworth, S. Hong, and S. Kazani Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness J Immunol 178 2007 496 502
22. J.S. Duffield, S. Hong, V.S. Vaidya, Y. Lu, G. Fredman, and C.N. Serhan Resolvin D series and protectin D1 mitigate acute kidney injury J Immunol 177 2006 5902 5911
23. R. Brinckmann, K. Schnurr, D. Heydeck, T. Rosenbach, G. Kolde, and H. Kuhn Membrane translocation of 15-lipoxygenase in hematopoietic cells is calcium-dependent and activates the oxygenase activity of the enzyme Blood 91 1998 64 74
24. H. Kuhn, and V.B. O'Donnell Inflammation and immune regulation by 12/15-lipoxygenases Prog Lipid Res 45 2006 334 356
25. B.H. Maskrey, A. Bermudez-Fajardo, A.H. Morgan, E. Stewart-Jones, V. Dioszeghy, and G.W. Taylor Activated platelets and monocytes generate four hydroxyphosphatidylethanolamines via lipoxygenase J Biol Chem 282 2007 20151 20163
26. C.P. Thomas, L.T. Morgan, B.H. Maskrey, R.C. Murphy, H. Kuhn, and S.L. Hazen Phospholipid-esterified eicosanoids are generated in agonist-activated human platelets and enhance tissue factor-dependent thrombin generation J Biol Chem 285 2010 6891 6903
27. A.H. Morgan, V. Dioszeghy, B.H. Maskrey, C.P. Thomas, S.R. Clark, and S.A. Mathie Phosphatidylethanolamine-esterified eicosanoids in the mouse: tissue localization and inflammation-dependent formation in Th-2 disease J Biol Chem 284 2009 21185 21191
28. V. Kenyon, I. Chorny, W.J. Carvajal, T.R. Holman, and M.P. Jacobson Novel human lipoxygenase inhibitors discovered using virtual screening with homology models J Med Chem 49 2006 1356 1363
29. V.B. O'Donnell, B. Maskrey, and G.W. Taylor Eicosanoids: generation and detection in mammalian cells Methods Mol Biol 462 2009 5 23
30. K. Ma, C.S. Nunemaker, R. Wu, S.K. Chakrabarti, D.A. Taylor-Fishwick, and J.L. Nadler 12-Lipoxygenase products reduce insulin secretion and {beta}-cell viability in human islets J Clin Endocrinol Metab 95 2010 887 893
31. M. Chen, Z.D. Yang, K.M. Smith, J.D. Carter, and J.L. Nadler Activation of 12-lipoxygenase in proinflammatory cytokine-mediated beta cell toxicity Diabetologia 48 2005 486 495
32. D.R. Laybutt, A. Sharma, D.C. Sgroi, J. Gaudet, S. Bonner-Weir, and G.C. Weir Genetic regulation of metabolic pathways in beta-cells disrupted by hyperglycemia J Biol Chem 277 2002 10912 10921
33. R. Natarajan, J.L. Gu, J. Rossi, N. Gonzales, L. Lanting, and L. Xu Elevated glucose and angiotensin II increase 12-lipoxygenase activity and expression in porcine aortic smooth muscle cells Proc Natl Acad Sci USA 90 1993 4947 4951
34. Y. Tokuyama, J. Sturis, A.M. DePaoli, J. Takeda, M. Stoffel, and J. Tang Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat Diabetes 44 1995 1447 1457
35. C.S. Nunemaker, M. Chen, H. Pei, S.D. Kimble, S.R. Keller, and J.D. Carter 12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by Western diet Am J Physiol Endocrinol Metab 295 2008 E1065 E1075
36. D.D. Sears, P.D. Miles, J. Chapman, J.M. Ofrecio, F. Almazan, and D. Thapar 12/15-lipoxygenase is required for the early onset of high fat diet-induced adipose tissue inflammation and insulin resistance in mice PLoS One 4 2009 e7250
37. D. Bleich, S. Chen, B. Zipser, D. Sun, C.D. Funk, and J.L. Nadler Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice J Clin Invest 103 1999 1431 1436
38. M. McDuffie, N.A. Maybee, S.R. Keller, B.K. Stevens, J.C. Garmey, and M.A. Morris Nonobese diabetic (NOD) mice congenic for a targeted deletion of 12/15-lipoxygenase are protected from autoimmune diabetes Diabetes 57 2008 199 208
39. J. Aliberti, S. Hieny, C. Reis e Sousa, C.N. Serhan, and A. Sher Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity Nat Immunol 3 2002 76 82
40. L. Zhao, C.A. Cuff, E. Moss, U. Wille, T. Cyrus, and E.A. Klein Selective interleukin-12 synthesis defect in 12/15-lipoxygenase-deficient macrophages associated with reduced atherosclerosis in a mouse model of familial hypercholesterolemia J Biol Chem 277 2002 35350 35356
41. M.K. Middleton, T. Rubinstein, and E. Pure Cellular and molecular mechanisms of the selective regulation of IL-12 production by 12/15-lipoxygenase J Immunol 176 2006 265 274
42. M.K. Middleton, A.M. Zukas, T. Rubinstein, M. Kinder, E.H. Wilson, and P. Zhu 12/15-lipoxygenase-dependent myeloid production of interleukin-12 is essential for resistance to chronic toxoplasmosis Infect Immun 77 2009 5690 5700
43. D. Bleich, S. Chen, J.L. Gu, L. Thomas, S. Scott, and N. Gonzales Interleukin-1 beta regulates the expression of a leukocyte type of 12-lipoxygenase in rat islets and RIN m5F cells Endocrinology 136 1995 5736 5744
44. D. Bleich, S. Chen, Y. Wen, and J.L. Nadler The stress-activated c-Jun protein kinase (JNK) is stimulated by lipoxygenase pathway product 12-HETE in RIN m5F cells Biochem Biophys Res Commun 230 1997 448 451
45. K.M. Prasad, P.R. Thimmalapura, E.A. Woode, and J.L. Nadler Evidence that increased 12-lipoxygenase expression impairs pancreatic beta cell function and viability Biochem Biophys Res Commun 308 2003 427 432
46. R.R. Nazarewicz, W.J. Zenebe, A. Parihar, M.S. Parihar, M. Vaccaro, and C. Rink 12(S)-hydroperoxyeicosatetraenoic acid (12-HETE) increases mitochondrial nitric oxide by increasing intramitochondrial calcium Arch Biochem Biophys 468 2007 114 120
47. O. Radmark 5-Lipoxygenase-derived leukotrienes: mediators also of atherosclerotic inflammation Arterioscler Thromb Vasc Biol 23 2003 1140 1142
48. S.J. Persaud, D. Muller, V.D. Belin, I. Kitsou-Mylona, H. Asare-Anane, and A. Papadimitriou The role of arachidonic acid and its metabolites in insulin secretion from human islets of langerhans Diabetes 56 2007 197 203
49. X. Han, S. Chen, Y. Sun, J.L. Nadler, and D. Bleich Induction of cyclooxygenase-2 gene in pancreatic beta-cells by 12-lipoxygenase pathway product 12-hydroxyeicosatetraenoic acid Mol Endocrinol 16 2002 2145 2154
50. Y.I. Miller, S. Viriyakosol, C.J. Binder, J.R. Feramisco, T.N. Kirkland, and J.L. Witztum Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells J Biol Chem 278 2003 1561 1568
51. Y.I. Miller, S. Viriyakosol, D.S. Worrall, A. Boullier, S. Butler, and J.L. Witztum Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages Arterioscler Thromb Vasc Biol 25 2005 1213 1219
52. S. Metz, M. VanRollins, R. Strife, W. Fujimoto, and R.P. Robertson Lipoxygenase pathway in islet endocrine cells. Oxidative metabolism of arachidonic acid promotes insulin release J Clin Invest 71 1983 1191 1205
53. S.A. Metz Glucose increases the synthesis of lipoxygenase-mediated metabolites of arachidonic acid in intact rat islets Proc Natl Acad Sci USA 82 1985 198 202
54. J. Turk, J.R. Colca, and M.L. McDaniel Arachidonic acid metabolism in isolated pancreatic islets. III. Effects of exogenous lipoxygenase products and inhibitors on insulin secretion Biochim Biophys Acta 834 1985 23 36
55. V.R. Shannon, S. Ramanadham, J. Turk, and M.J. Holtzman Selective expression of an arachidonate 12-lipoxygenase by pancreatic islet beta-cells Am J Physiol 263 1992 E828 E836
56. H. Kawajiri, D. Zhuang, N. Qiao, T. Yoshimoto, M. Yamamoto, and S. Iseki Expression of arachidonate 12-lipoxygenase in rat tissues: a possible role in glucagon secretion J Histochem Cytochem 48 2000 1411 1419
57. I.G. Obrosova, O. Ilnytska, V.V. Lyzogubov, I.A. Pavlov, N. Mashtalir, and J.L. Nadler High-fat diet induced neuropathy of pre-diabetes and obesity: effects of "healthy" diet and aldose reductase inhibition Diabetes 56 2007 2598 2608
58. P. Watcho, R. Stavniichuk, D.M. Ribnicky, I. Raskin, and I.G. Obrosova High-fat diet-induced neuropathy of prediabetes and obesity: effect of PMI-5011, an ethanolic extract of Artemisia dracunculus L. Mediators Inflamm 2010 2010 268547
59. Stavniichuk R, Drel VR, Shevalye H, Vareniuk I, Stevens MJ, Nadler JL, et al. Role of 12/15-lipoxygenase in nitrosative stress and peripheral prediabetic and diabetic neuropathies. Free Radic Biol Med 2010.
60. A.J. Augustin, F.H. Grus, F. Koch, and M. Spitznas Detection of eicosanoids in epiretinal membranes of patients suffering from proliferative vitreoretinal diseases Br J Ophthalmol 81 1997 58 60
61. M.L. Schwartzman, P. Iserovich, K. Gotlinger, L. Bellner, M.W. Dunn, and M. Sartore Profile of lipid and protein autacoids in diabetic vitreous correlates with the progression of diabetic retinopathy Diabetes 59 2010 1780 1788
62. R.A. Gubitosi-Klug, R. Talahalli, Y. Du, J.L. Nadler, and T.S. Kern 5-Lipoxygenase, but not 12/15-lipoxygenase, contributes to degeneration of retinal capillaries in a mouse model of diabetic retinopathy Diabetes 57 2008 1387 1393
63. L. Madsen, R.K. Petersen, M.B. Sorensen, C. Jorgensen, P. Hallenborg, and L. Pridal Adipocyte differentiation of 3T3-L1 preadipocytes is dependent on lipoxygenase activity during the initial stages of the differentiation process Biochem J 375 2003 539 549
64. H. Green, and M. Meuth An established pre-adipose cell line and its differentiation in culture Cell 3 1974 127 133
65. G.J. Hausman, D.R. Campion, and R.J. Martin Search for the adipocyte precursor cell and factors that promote its differentiation J Lipid Res 21 1980 657 670
66. Y. Barak, M.C. Nelson, E.S. Ong, Y.Z. Jones, P. Ruiz-Lozano, and K.R. Chien PPAR gamma is required for placental, cardiac, and adipose tissue development Mol Cell 4 1999 585 595
67. N. Kubota, Y. Terauchi, H. Miki, H. Tamemoto, T. Yamauchi, and K. Komeda PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance Mol Cell 4 1999 597 609
68. E.D. Rosen, P. Sarraf, A.E. Troy, G. Bradwin, K. Moore, and D.S. Milstone PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro Mol Cell 4 1999 611 617
69. K. Yu, W. Bayona, C.B. Kallen, H.P. Harding, C.P. Ravera, and G. McMahon Differential activation of peroxisome proliferator-activated receptors by eicosanoids J Biol Chem 270 1995 23975 23983
70. L. Nagy, P. Tontonoz, J.G. Alvarez, H. Chen, and R.M. Evans Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma Cell 93 1998 229 240
71. J.T. Huang, J.S. Welch, M. Ricote, C.J. Binder, T.M. Willson, and C. Kelly Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase Nature 400 1999 378 382
72. S.B. Shappell, R.A. Gupta, S. Manning, R. Whitehead, W.E. Boeglin, and C. Schneider 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells Cancer Res 61 2001 497 503
73. K.R. Kozak, R.A. Gupta, J.S. Moody, C. Ji, W.E. Boeglin, and R.N. DuBois 15-Lipoxygenase metabolism of 2-arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonist J Biol Chem 277 2002 23278 23286
74. C. Nugent, J.B. Prins, J.P. Whitehead, J.M. Wentworth, V.K. Chatterjee, and S. O'Rahilly Arachidonic acid stimulates glucose uptake in 3T3-L1 adipocytes by increasing GLUT1 and GLUT4 levels at the plasma membrane. Evidence for involvement of lipoxygenase metabolites and peroxisome proliferator-activated receptor gamma J Biol Chem 276 2001 9149 9157
75. E.N. Johnson, L.B. Nanney, J. Virmani, J.A. Lawson, and C.D. Funk Basal transepidermal water loss is increased in platelet-type 12-lipoxygenase deficient mice J Invest Dermatol 112 1999 861 865
76. Chakrabarti SK, Cole BK, Wen Y, Keller SR, Nadler JL. 12/15-Lipoxygenase Products Induce Inflammation and Impair Insulin Signaling in 3T3-L1 Adipocytes. Obesity (Silver Spring), 2009.
77. D. Sun, and C.D. Funk Disruption of 12/15-lipoxygenase expression in peritoneal macrophages. Enhanced utilization of the 5-lipoxygenase pathway and diminished oxidation of low density lipoprotein J Biol Chem 271 1996 24055 24062
78. P. Hallenborg, C. Jorgensen, R.K. Petersen, S. Feddersen, P. Araujo, and P. Markt Epidermis-type lipoxygenase 3 regulates adipocyte differentiation and peroxisome proliferator-activated receptor gamma activity Mol Cell Biol 30 2010 4077 4091
79. J.C. Mackall, A.K. Student, S.E. Polakis, and M.D. Lane Induction of lipogenesis during differentiation in a "preadipocyte" cell line J Biol Chem 251 1976 6462 6464
80. D.J. Dyck Adipokines as regulators of muscle metabolism and insulin sensitivity Appl Physiol Nutr Metab 34 2009 396 402
81. V. Catalan, J. Gomez-Ambrosi, A. Rodriguez, B. Ramirez, C. Silva, and F. Rotellar Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans J Mol Med 87 2009 803 813
82. Y. Wang, K.S. Lam, E.W. Kraegen, G. Sweeney, J. Zhang, and A.W. Tso Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans Clin Chem 53 2007 34 41
83. J. Zhang, Y. Wu, Y. Zhang, D. Leroith, D.A. Bernlohr, and X. Chen The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages Mol Endocrinol 22 2008 1416 1426
84. I.K. Law, A. Xu, K.S. Lam, T. Berger, T.W. Mak, and P.M. Vanhoutte Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity Diabetes 59 2010 872 882
85. B.K. Cole, S.R. Keller, R. Wu, J.D. Carter, J.L. Nadler, and C.S. Nunemaker Valsartan protects pancreatic islets and adipose tissue from the inflammatory and metabolic consequences of a high-fat diet in mice Hypertension 55 2010 715 721
86. H. Kuhn, and B.J. Thiele The diversity of the lipoxygenase family. Many sequence data but little information on biological significance FEBS Lett 449 1999 7 11
87. N. Noguchi, H. Yamashita, J. Hamahara, A. Nakamura, H. Kuhn, and E. Niki The specificity of lipoxygenase-catalyzed lipid peroxidation and the effects of radical-scavenging antioxidants Biol Chem 383 2002 619 626
88. S.P. Khanapure, D.S. Garvey, D.R. Janero, and L.G. Letts Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers Curr Top Med Chem 7 2007 311 340
89. C.N. Serhan, and N. Chiang Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus Br J Pharmacol 153 Suppl 1 2008 S200 S215
90. C.N. Serhan, N. Chiang, and T.E. Van Dyke Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators Nat Rev Immunol 8 2008 349 361
91. C.N. Serhan, S. Yacoubian, and R. Yang Anti-inflammatory and proresolving lipid mediators Ann Rev Pathol 3 2008 279 312
92. Y. Chawengsub, K.M. Gauthier, and W.B. Campbell Role of arachidonic acid lipoxygenase metabolites in the regulation of vascular tone Am J Physiol Heart Circ Physiol 297 2009 H495 H507
93. N.T. Aggarwal, B.B. Holmes, L. Cui, H. Viita, S. Yla-Herttuala, and W.B. Campbell Adenoviral expression of 15-lipoxygenase-1 in rabbit aortic endothelium: role in arachidonic acid-induced relaxation Am J Physiol Heart Circ Physiol 292 2007 H1033 H1041
94. A.R. Brash, W.E. Boeglin, and M.S. Chang Discovery of a second 15S-lipoxygenase in humans Proc Natl Acad Sci USA 94 1997 6148 6152
95. X. Tang, B.B. Holmes, K. Nithipatikom, C.J. Hillard, H. Kuhn, and W.B. Campbell Reticulocyte 15-lipoxygenase-I is important in acetylcholine-induced endothelium-dependent vasorelaxation in rabbit aorta Arterioscler Thromb Vasc Biol 26 2006 78 84
96. E. Sigal, D. Grunberger, C.S. Craik, G.H. Caughey, and J.A. Nadel Arachidonate 15-lipoxygenase (omega-6 lipoxygenase) from human leukocytes. Purification and structural homology to other mammalian lipoxygenases J Biol Chem 263 1988 5328 5332
97. T.K. Uski, and E.D. Hogestatt Effects of various cyclooxygenase and lipoxygenase metabolites on guinea-pig cerebral arteries Gen Pharmacol 23 1992 109 113
98. H. Rubbo, and V. O'Donnell Nitric oxide, peroxynitrite and lipoxygenase in atherogenesis: mechanistic insights Toxicology 208 2005 305 317
99. H.G. Holzhutter, R. Wiesner, J. Rathmann, R. Stosser, and H. Kuhn A kinetic model for the interaction of nitric oxide with a mammalian lipoxygenase Eur J Biochem 245 1997 608 616
100. M.J. Coffey, R. Natarajan, P.H. Chumley, B. Coles, P.R. Thimmalapura, and M. Nowell Catalytic consumption of nitric oxide by 12/15-lipoxygenase: inhibition of monocyte soluble guanylate cyclase activation Proc Natl Acad Sci USA 98 2001 8006 8011
101. P.B. Anning, B. Coles, A. Bermudez-Fajardo, P.E. Martin, B.S. Levison, and S.L. Hazen Elevated endothelial nitric oxide bioactivity and resistance to angiotensin-dependent hypertension in 12/15-lipoxygenase knockout mice Am J Pathol 166 2005 653 662
102. D. Zhu, M. Medhora, W.B. Campbell, N. Spitzbarth, J.E. Baker, and E.R. Jacobs Chronic hypoxia activates lung 15-lipoxygenase, which catalyzes production of 15-HETE and enhances constriction in neonatal rabbit pulmonary arteries Circ Res. 92 2003 992 1000
103. S.L. Pfister, N. Spitzbarth, W. Edgemond, and W.B. Campbell Vasorelaxation by an endothelium-derived metabolite of arachidonic acid Am J Physiol 270 1996 H1021 H1030
104. S.L. Pfister, N. Spitzbarth, K. Nithipatikom, W.S. Edgemond, J.R. Falck, and W.B. Campbell Identification of the 11, 14, 15- and 11, 12, 15-trihydroxyeicosatrienoic acids as endothelium-derived relaxing factors of rabbit aorta J Biol Chem 273 1998 30879 30887
105. Y. Chawengsub, K.M. Gauthier, K. Nithipatikom, B.D. Hammock, J.R. Falck, and D. Narsimhaswamy Identification of 13-hydroxy-14, 15-epoxyeicosatrienoic acid as an acid-stable endothelium-derived hyperpolarizing factor in rabbit arteries J Biol Chem 284 2009 31280 31290
106. S.A. Moore, A.A. Spector, and M.N. Hart Eicosanoid metabolism in cerebromicrovascular endothelium Am J Physiol 254 1988 C37 C44
107. M.H. Zink, C.L. Oltman, T. Lu, P.V. Katakam, T.L. Kaduce, and H. Lee 12-lipoxygenase in porcine coronary microcirculation: implications for coronary vasoregulation Am J Physiol Heart Circ Physiol 280 2001 H693 H704
108. A.W. Miller, P.V. Katakam, H.C. Lee, C.D. Tulbert, D.W. Busija, and N.L. Weintraub Arachidonic acid-induced vasodilation of rat small mesenteric arteries is lipoxygenase-dependent J Pharmacol Exp Ther 304 2003 139 144
109. F.M. Faraci, C.G. Sobey, S. Chrissobolis, D.D. Lund, D.D. Heistad, and N.L. Weintraub Arachidonate dilates basilar artery by lipoxygenase-dependent mechanism and activation of K(+) channels Am J Physiol Regul Integr Comp Physiol 281 2001 R246 R253
110. B.T. Larsen, H. Miura, O.A. Hatoum, W.B. Campbell, B.D. Hammock, and D.C. Zeldin Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition Am J Physiol Heart Circ Physiol 290 2006 H491 H499
111. Y.H. Ma, D.R. Harder, J.E. Clark, and R.J. Roman Effects of 12-HETE on isolated dog renal arcuate arteries Am J Physiol 261 1991 H451 H456
112. S.L. Pfister, N. Spitzbarth, K. Nithipatikom, J.R. Falck, and W.B. Campbell Metabolism of 12-hydroperoxyeicosatetraenoic acid to vasodilatory trioxilin C3 by rabbit aorta Biochim Biophys Acta 1622 2003 6 13
113. O. Laneuville, E.J. Corey, R. Couture, and C.R. Pace-Asciak Hepoxilin A3 (HxA3) is formed by the rat aorta and is metabolized into HxA3-C, a glutathione conjugate Biochim Biophys Acta 1084 1991 60 68
114. C.N. Serhan Lipoxin biosynthesis and its impact in inflammatory and vascular events Biochim Biophys Acta 1212 1994 1 25
115. B.N. Setty, J.E. Graeber, and M.J. Stuart The mitogenic effect of 15- and 12-hydroxyeicosatetraenoic acid on endothelial cells may be mediated via diacylglycerol kinase inhibition J Biol Chem 262 1987 17613 17622
116. G.N. Rao, A.S. Baas, W.C. Glasgow, T.E. Eling, M.S. Runge, and R.W. Alexander Activation of mitogen-activated protein kinases by arachidonic acid and its metabolites in vascular smooth muscle cells J Biol Chem 269 1994 32586 32591
117. R.S. Dwarakanath, S. Sahar, M.A. Reddy, D. Castanotto, J.J. Rossi, and R. Natarajan Regulation of monocyte chemoattractant protein-1 by the oxidized lipid, 13-hydroperoxyoctadecadienoic acid, in vascular smooth muscle cells via nuclear factor-kappa B (NF-kappa B) J Mol Cell Cardiol 36 2004 585 595
118. J. Ma, S. Liang, Z. Wang, L. Zhang, J. Jiang, and J. Zheng ROCK pathway participates in the processes that 15-hydroxyeicosatetraenoic acid (15-HETE) mediated the pulmonary vascular remodeling induced by hypoxia in rat J Cell Physiol 222 2010 82 94
119. L.L. Stoll, M.R. Morland, and A.A. Spector 13-HODE increases intracellular calcium in vascular smooth muscle cells Am J Physiol 266 1994 C990 C996
120. M.K. Patricia, R. Natarajan, A.N. Dooley, F. Hernandez, J.L. Gu, and J.A. Berliner Adenoviral delivery of a leukocyte-type 12 lipoxygenase ribozyme inhibits effects of glucose and platelet-derived growth factor in vascular endothelial and smooth muscle cells Circ Res 88 2001 659 665
121. K.R. Chava, M. Karpurapu, D. Wang, M. Bhanoori, V. Kundumani-Sridharan, and Q. Zhang CREB-mediated IL-6 expression is required for 15(S)- hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migration Arterioscler Thromb Vasc Biol 29 2009 809 815
122. H.S. Potula, D. Wang, D.V. Quyen, N.K. Singh, V. Kundumani-Sridharan, and M. Karpurapu Src-dependent STAT-3-mediated expression of monocyte chemoattractant protein-1 is required for 15(S)-hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migration J Biol Chem 284 2009 31142 31155
123. M.A. Reddy, Y.S. Kim, L. Lanting, and R. Natarajan Reduced growth factor responses in vascular smooth muscle cells derived from 12/15-lipoxygenase- deficient mice Hypertension 41 2003 1294 1300
124. S. Wang, Y. Wang, J. Jiang, R. Wang, L. Li, and Z. Qiu 15-HETE protects rat pulmonary arterial smooth muscle cells from apoptosis via the PI3K/Akt pathway Prostaglandins Other Lipid Mediat 91 2010 51 60
125. Hersberger M. Review: Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins. Clin Chem Lab Med. 2010.
126. D. Harats, A. Shaish, J. George, M. Mulkins, H. Kurihara, and H. Levkovitz Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice Arterioscler Thromb Vasc Biol 20 2000 2100 2105
127. J. Shen, E. Herderick, J.F. Cornhill, E. Zsigmond, H.S. Kim, and H. Kuhn Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development J Clin Invest 98 1996 2201 2208
128. F. Trebus, D. Heydeck, I. Schimke, C. Gerth, and H. Kuhn Transient experimental anemia in cholesterol-fed rabbits induces systemic overexpression of the reticulocyte-type 15-lipoxygenase and protects from aortic lipid deposition Prostaglandins Leukot Essent Fatty Acids 67 2002 419 428
129. T. Cyrus, J.L. Witztum, D.J. Rader, R. Tangirala, S. Fazio, and M.F. Linton Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice J Clin Invest 103 1999 1597 1604
130. T. Cyrus, D. Pratico, L. Zhao, J.L. Witztum, D.J. Rader, and J. Rokach Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice Circulation 103 2001 2277 2282
131. Y. Huo, L. Zhao, M.C. Hyman, P. Shashkin, B.L. Harry, and T. Burcin Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice Circulation 110 2004 2024 2031
132. N. Chiang, M. Arita, and C.N. Serhan Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX Prostaglandins Leukot Essent Fatty Acids 73 2005 163 177
133. D. Poeckel, K.A. Zemski Berry, R.C. Murphy, and C.D. Funk Dual 12/15- and 5-lipoxygenase deficiency in macrophages alters arachidonic acid metabolism and attenuates peritonitis and atherosclerosis in ApoE knock-out mice J Biol Chem 284 2009 21077 21089
134. J. Belkner, R. Wiesner, J. Rathman, J. Barnett, E. Sigal, and H. Kuhn Oxygenation of lipoproteins by mammalian lipoxygenases Eur J Biochem 213 1993 251 261
135. S.M. Rankin, S. Parthasarathy, and D. Steinberg Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages J Lipid Res 32 1991 449 456
136. F. Sigari, C. Lee, J.L. Witztum, and P.D. Reaven Fibroblasts that overexpress 15-lipoxygenase generate bioactive and minimally modified LDL Arterioscler Thromb Vasc Biol 17 1997 3639 3645
137. V.A. Folcik, R. Aamir, and M.K. Cathcart Cytokine modulation of LDL oxidation by activated human monocytes Arterioscler Thromb Vasc Biol 17 1997 1954 1961
138. H. Zhu, Y. Takahashi, W. Xu, H. Kawajiri, T. Murakami, and M. Yamamoto Low density lipoprotein receptor-related protein-mediated membrane translocation of 12/15-lipoxygenase is required for oxidation of low density lipoprotein by macrophages J Biol Chem 278 2003 13350 13355
139. Y. Takahashi, H. Zhu, W. Xu, T. Murakami, T. Iwasaki, and H. Hattori Selective uptake and efflux of cholesteryl linoleate in LDL by macrophages expressing 12/15-lipoxygenase Biochem Biophys Res Commun 338 2005 128 135
140. M.H. Nagelin, S. Srinivasan, J. Lee, J.L. Nadler, and C.C. Hedrick 12/15-Lipoxygenase activity increases the degradation of macrophage ATP-binding cassette transporter G1 Arterioscler Thromb Vasc Biol 28 2008 1811 1819
141. M.H. Nagelin, S. Srinivasan, J.L. Nadler, and C.C. Hedrick Murine 12/15-lipoxygenase regulates ATP-binding cassette transporter G1 protein degradation through p38- and JNK2-dependent pathways J Biol Chem 284 2009 31303 31314
142. M. Hersberger, and A. von Eckardstein Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment Drugs 63 2003 1907 1945
143. G.D. Norata, A. Pirillo, and A.L. Catapano Modified HDL: biological and physiopathological consequences Nutr Metab Cardiovasc Dis 16 2006 371 386
144. A. Pirillo, P. Uboldi, H. Kuhn, and A.L. Catapano 15-Lipoxygenase- mediated modification of high-density lipoproteins impairs SR-BI- and ABCA1-dependent cholesterol efflux from macrophages Biochim Biophys Acta 1761 2006 292 300
145. A. Pirillo, P. Uboldi, C. Bolego, H. Kuhn, and A.L. Catapano The 15-lipoxygenase-modified high density lipoproteins 3 fail to inhibit the TNF-alpha-induced inflammatory response in human endothelial cells J Immunol 181 2008 2821 2830
146. J.A. Kim, J.L. Gu, R. Natarajan, J.A. Berliner, and J.L. Nadler A leukocyte type of 12-lipoxygenase is expressed in human vascular and mononuclear cells. Evidence for upregulation by angiotensin II Arterioscler Thromb Vasc Biol 15 1995 942 948
147. K.B. Reilly, S. Srinivasan, M.E. Hatley, M.K. Patricia, J. Lannigan, and D.T. Bolick 12/15-Lipoxygenase activity mediates inflammatory monocyte/endothelial interactions and atherosclerosis in vivo J Biol Chem 279 2004 9440 9450
148. J. Wolle, K.A. Welch, L.J. Devall, J.A. Cornicelli, and U. Saxena Transient overexpression of human 15-lipoxygenase in aortic endothelial cells enhances tumor necrosis factor-induced vascular cell adhesion molecule-1 gene expression Biochem Biophys Res Commun 220 1996 310 314
149. H. Viita, C.K. Sen, S. Roy, T. Siljamaki, T. Nikkari, and S. Yla-Herttuala High expression of human 15-lipoxygenase induces NF-kappaB-mediated expression of vascular cell adhesion molecule 1, intercellular adhesion molecule 1, and T-cell adhesion on human endothelial cells Antioxid Redox Signal 1 1999 83 96
150. D.T. Bolick, A.W. Orr, A. Whetzel, S. Srinivasan, M.E. Hatley, and M.A. Schwartz 12/15-lipoxygenase regulates intercellular adhesion molecule-1 expression and monocyte adhesion to endothelium through activation of RhoA and nuclear factor-kappaB Arterioscler Thromb Vasc Biol 25 2005 2301 2307
151. E.K. Rydberg, A. Krettek, C. Ullstrom, K. Ekstrom, P.A. Svensson, and L.M. Carlsson Hypoxia increases LDL oxidation and expression of 15-lipoxygenase-2 in human macrophages Arterioscler Thromb Vasc Biol 24 2004 2040 2045
152. K.N. Danielsson, E.K. Rydberg, M. Ingelsten, L.M. Akyurek, P. Jirholt, and C. Ullstrom 15-Lipoxygenase-2 expression in human macrophages induces chemokine secretion and T cell migration Atherosclerosis 199 2008 34 40
153. R.J. Smith, J.M. Justen, E.G. Nidy, L.M. Sam, and J.E. Bleasdale Transmembrane signaling in human polymorphonuclear neutrophils: 15(S)-hydroxy-(5Z, 8Z, 11Z, 13E)-eicosatetraenoic acid modulates receptor agonist-triggered cell activation Proc Natl Acad Sci USA 90 1993 7270 7274
154. S. Takata, A. Papayianni, M. Matsubara, W. Jimenez, P.H. Pronovost, and H.R. Brady 15-Hydroxyeicosatetraenoic acid inhibits neutrophil migration across cytokine-activated endothelium Am J Pathol 145 1994 541 549
155. S. Takata, M. Matsubara, P.G. Allen, P.A. Janmey, C.N. Serhan, and H.R.
156. M.R. Buchanan, M.C. Bertomeu, T.A. Haas, F.W. Orr, and L.L. Eltringham-Smith Localization of 13-hydroxyoctadecadienoic acid and the vitronectin receptor in human endothelial cells and endothelial cell/platelet interactions in vitro Blood 81 1993 3303 3312
157. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 79 82
158. R. Natarajan, R.G. Gerrity, J.L. Gu, L. Lanting, L. Thomas, and J.L. Nadler Role of 12-lipoxygenase and oxidant stress in hyperglycaemia-induced acceleration of atherosclerosis in a diabetic pig model Diabetologia 45 2002 125 133
159. H. Pei, J. Gu, P.R. Thimmalapura, A. Mison, and J.L. Nadler Activation of the 12-lipoxygenase and signal transducer and activator of transcription pathway during neointima formation in a model of the metabolic syndrome Am J Physiol Endocrinol Metab 290 2006 E92 E102
160. J.L. Gu, D. Veerapanane, J. Rossi, R. Natarajan, L. Thomas, and J. Nadler Ribozyme-mediated inhibition of expression of leukocyte-type 12-lipoxygenase in porcine aortic vascular smooth muscle cells Circ Res 77 1995 14 20
161. Y. Wen, J. Gu, X. Peng, G. Zhang, and J. Nadler Overexpression of 12-lipoxygenase and cardiac fibroblast hypertrophy Trends Cardiovasc Med 13 2003 129 136
162. T.H. Lee, C.E. Horton, U. Kyan-Aung, D. Haskard, A.E. Crea, and B.W. Spur Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-l-methionyl-l-leucyl-l-phenylalanine Clin Sci (Lond) 77 1989 195 203
163. S.P. Colgan, C.N. Serhan, C.A. Parkos, C. Delp-Archer, and J.L. Madara Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers J Clin Invest 92 1993 75 82
164. C. Godson, S. Mitchell, K. Harvey, N.A. Petasis, N. Hogg, and H.R. Brady Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages J Immunol 164 2000 1663 1667
165. J.F. Maddox, and C.N. Serhan Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction J Exp Med 183 1996 137 146
166. A. Mantovani, A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati The chemokine system in diverse forms of macrophage activation and polarization Trends Immunol 25 2004 677 686
167. S. Mitchell, G. Thomas, K. Harvey, D. Cottell, K. Reville, and G. Berlasconi Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo J Am Soc Nephrol 13 2002 2497 2507
168. A.J. Merched, K. Ko, K.H. Gotlinger, C.N. Serhan, and L. Chan Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators Faseb J 22 2008 3595 3606
169. M. Arita, T. Ohira, Y.P. Sun, S. Elangovan, N. Chiang, and C.N. Serhan Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation J Immunol 178 2007 3912 3917
170. J.H. Lee, J.H. O'Keefe, C.J. Lavie, R. Marchioli, and W.S. Harris Omega-3 fatty acids for cardioprotection Mayo Clin Proc 83 2008 324 332
171. S. Yla-Herttuala, M.E. Rosenfeld, S. Parthasarathy, E. Sigal, T. Sarkioja, and J.L. Witztum Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts J Clin Invest 87 1991 1146 1152
172. H. Kuhn, D. Heydeck, I. Hugou, and C. Gniwotta In vivo action of 15-lipoxygenase in early stages of human atherogenesis J Clin Invest 99 1997 888 893
173. L.M. Hulten, F.J. Olson, H. Aberg, J. Carlsson, L. Karlstrom, and J. Boren 15-Lipoxygenase-2 is expressed in macrophages in human carotid plaques and regulated by hypoxia-inducible factor-1alpha Eur J Clin Invest 40 2010 11 17
174. J. Wittwer, M. Bayer, A. Mosandl, J. Muntwyler, and M. Hersberger The c.-292C>T promoter polymorphism increases reticulocyte-type 15-lipoxygenase-1 activity and could be atheroprotective Clin Chem Lab Med 45 2007 487 492
175. T.L. Assimes, J.W. Knowles, J.R. Priest, A. Basu, A. Borchert, and K.A. Volcik A near null variant of 12/15-LOX encoded by a novel SNP in ALOX15 and the risk of coronary artery disease Atherosclerosis 198 2008 136 144
176. K.P. Burdon, M.E. Rudock, A.B. Lehtinen, C.D. Langefeld, D.W. Bowden, and T.C. Register Human lipoxygenase pathway gene variation and association with markers of subclinical atherosclerosis in the diabetes heart study Mediators Inflamm 2010 2010 170153
177. U.P. Kelavkar, J.B. Nixon, C. Cohen, D. Dillehay, T.E. Eling, and K.F. Badr Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis Carcinogenesis 22 2001 1765 1773
178. H. Viita, J. Markkanen, E. Eriksson, M. Nurminen, K. Kinnunen, and M. Babu 15-lipoxygenase-1 prevents vascular endothelial growth factor A- and placental growth factor-induced angiogenic effects in rabbit skeletal muscles via reduction in growth factor mRNA levels, NO bioactivity, and downregulation of VEGF receptor 2 expression Circ Res 102 2008 177 184
179. D. Harats, D. Ben-Shushan, H. Cohen, A. Gonen, I. Barshack, and I. Goldberg Inhibition of carcinogenesis in transgenic mouse models over-expressing 15-lipoxygenase in the vascular wall under the control of murine preproendothelin-1 promoter Cancer Lett 229 2005 127 134
180. H. Viita, K. Kinnunen, E. Eriksson, J. Lahteenvuo, M. Babu, and G. Kalesnykas Intravitreal adenoviral 15-lipoxygenase-1 gene transfer prevents vascular endothelial growth factor A-induced neovascularization in rabbit eyes Hum Gene Ther 20 2009 1679 1686
181. M. Schneider, M. Wortmann, P.K. Mandal, W. Arpornchayanon, K. Jannasch, and F. Alves Absence of glutathione peroxidase 4 affects tumor angiogenesis through increased 12/15-lipoxygenase activity Neoplasia 12 2010 254 263
182. S. Krishnamoorthy, R. Jin, Y. Cai, K.R. Maddipati, D. Nie, and G. Pages 12-Lipoxygenase and the regulation of hypoxia-inducible factor in prostate cancer cells Exp Cell Res 316 2010 1706 1715
183. V. Kundumani-Sridharan, J. Niu, D. Wang, D. Van Quyen, Q. Zhang, and N.K. Singh 15(S)-hydroxyeicosatetraenoic acid-induced angiogenesis requires Src-mediated Egr-1-dependent rapid induction of FGF-2 expression Blood 115 2010 2105 2116
184. A.J. Leedom, A.B. Sullivan, B. Dong, D. Lau, and K. Gronert Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury Am J Pathol 176 2010 74 84
185. J.D. Imig Eicosanoids and renal vascular function in diseases Clin Sci (Lond) 111 2006 21 34
186. C.M. Hao, and M.D. Breyer Roles of lipid mediators in kidney injury Semin Nephrol 27 2007 338 351
187. C.M. Hao, and M.D. Breyer Physiologic and pathophysiologic roles of lipid mediators in the kidney Kidney Int 71 2007 1105 1115
188. S.S. Yiu, X. Zhao, E.W. Inscho, and J.D. Imig 12-Hydroxyeicosatetraenoic acid participates in angiotensin II afferent arteriolar vasoconstriction by activating L-type calcium channels J Lipid Res 44 2003 2391 2399
189. T. Katoh, K. Takahashi, D.K. DeBoer, C.N. Serhan, and K.F. Badr Renal hemodynamic actions of lipoxins in rats: a comparative physiological study Am J Physiol 263 1992 F436 F442
190. F. Saito, M.T. Hori, Y. Ideguchi, M. Berger, M. Golub, and N. Stern 12-Lipoxygenase products modulate calcium signals in vascular smooth muscle cells Hypertension 20 1992 138 143
191. Z.G. Xu, L.N. Miao, Y.C. Cui, Y. Jia, H. Yuan, and M. Wu Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli Nephrol Dial Transplant 24 2009 1744 1752
192. M.J. Coffey, B. Coles, and V.B. O'Donnell Interactions of nitric oxide-derived reactive nitrogen species with peroxidases and lipoxygenases Free Radic Res 35 2001 447 464
193. J.L. Nadler, S. Goodson, M. Tuck, and N. Stern Role of lipoxygenase metabolites in angiotensin-induced aldosterone synthesis Adv Prostaglandin Thromboxane Leukot Res 17B 1987 701 703
194. J.L. Nadler, R. Natarajan, and N. Stern Specific action of the lipoxygenase pathway in mediating angiotensin II-induced aldosterone synthesis in isolated adrenal glomerulosa cells J Clin Invest 80 1987 1763 1769
195. R. Limor, M. Kaplan, O. Sharon, E. Knoll, M. Naidich, and G. Weisinger Aldosterone up-regulates 12- and 15-lipoxygenase expression and LDL oxidation in human vascular smooth muscle cells J Cell Biochem 108 2009 1203 1210
196. D. Gonzalez-Nunez, J. Claria, F. Rivera, and E. Poch Increased levels of 12(S)-HETE in patients with essential hypertension Hypertension 37 2001 334 338
197. L.F. Quintana, B. Guzman, S. Collado, J. Claria, and E. Poch A coding polymorphism in the 12-lipoxygenase gene is associated to essential hypertension and urinary 12(S)-HETE Kidney Int 69 2006 526 530
198. W.C. Chang, and G.W. Su Increase in 12-lipoxygenase activity in platelets of spontaneously hypertensive rats Biochem Biophys Res Commun 127 1985 642 648
199. M. Sasaki, M.T. Hori, T. Hino, M.S. Golub, and M.L. Tuck Elevated 12-lipoxygenase activity in the spontaneously hypertensive rat Am J Hypertens 10 1997 371 378
200. K. Nozawa, M.L. Tuck, M. Golub, P. Eggena, J.L. Nadler, and N. Stern Inhibition of lipoxygenase pathway reduces blood pressure in renovascular hypertensive rats Am J Physiol 259 1990 H1774 H1780
201. A. DelliPizzi, H. Guan, X. Tong, H. Takizawa, and A. Nasjletti Lipoxygenase-dependent mechanisms in hypertension Clin Exp Hypertens 22 2000 181 192
202. D. Gonzalez-Nunez, M. Sole, R. Natarajan, and E. Poch 12-Lipoxygenase metabolism in mouse distal convoluted tubule cells Kidney Int 67 2005 178 186
203. Z.G. Xu, S.L. Li, L. Lanting, Y.S. Kim, N. Shanmugam, and M.A. Reddy Relationship between 12/15-lipoxygenase and COX-2 in mesangial cells: potential role in diabetic nephropathy Kidney Int 69 2006 512 519
204. S.W. Kang, R. Natarajan, A. Shahed, C.C. Nast, J. LaPage, and P. Mundel Role of 12-lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen alpha5(IV) in experimental diabetic nephropathy and in glucose-stimulated podocytes J Am Soc Nephrol 14 2003 3178 3187
205. S.W. Kang, S.G. Adler, C.C. Nast, J. LaPage, J.L. Gu, and J.L. Nadler 12-lipoxygenase is increased in glucose-stimulated mesangial cells and in experimental diabetic nephropathy Kidney Int 59 2001 1354 1362
206. I. Antonipillai, J. Nadler, E.J. Vu, S. Bughi, R. Natarajan, and R. Horton A 12-lipoxygenase product, 12-hydroxyeicosatetraenoic acid, is increased in diabetics with incipient and early renal disease J Clin Endocrinol Metab 81 1996 1940 1945
207. M.K. Patricia, J.A. Kim, C.M. Harper, P.T. Shih, J.A. Berliner, and R. Natarajan Lipoxygenase products increase monocyte adhesion to human aortic endothelial cells Arterioscler Thromb Vasc Biol 19 1999 2615 2622
208. Y.S. Kim, Z.G. Xu, M.A. Reddy, S.L. Li, L. Lanting, and K. Sharma Novel interactions between TGF-{beta}1 actions and the 12/15-lipoxygenase pathway in mesangial cells J Am Soc Nephrol 16 2005 352 362
209. Y.S. Kim, M.A. Reddy, L. Lanting, S.G. Adler, and R. Natarajan Differential behavior of mesangial cells derived from 12/15-lipoxygenase knockout mice relative to control mice Kidney Int 64 2003 1702 1714
210. B. McMahon, and C. Godson Lipoxins: endogenous regulators of inflammation Am J Physiol Renal Physiol 286 2004 F189 F201
211. N.E. Kieran, P. Maderna, and C. Godson Lipoxins: potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease Kidney Int 65 2004 1145 1154
212. A. Papayianni, C.N. Serhan, and H.R. Brady Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells J Immunol 156 1996 2264 2272
213. B. McMahon, D. Mitchell, R. Shattock, F. Martin, H.R. Brady, and C. Godson Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation Faseb J 16 2002 1817 1819
214. B. McMahon, C. Stenson, F. McPhillips, A. Fanning, H.R. Brady, and C. Godson Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors J Biol Chem 275 2000 27566 27575
215. N.E. Kieran, P.P. Doran, S.B. Connolly, M.C. Greenan, D.F. Higgins, and M. Leonard Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog Kidney Int 64 2003 480 492
216. K.A. Munger, A. Montero, M. Fukunaga, S. Uda, T. Yura, and E. Imai Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis Proc Natl Acad Sci USA 96 1999 13375 13380
217. M.O. Leonard, K. Hannan, M.J. Burne, D.W. Lappin, P. Doran, and P. Coleman 15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure J Am Soc Nephrol 13 2002 1657 1662
218. I.R. Hassan, and K. Gronert Acute changes in dietary omega-3 and omega-6 polyunsaturated fatty acids have a pronounced impact on survival following ischemic renal injury and formation of renoprotective docosahexaenoic acid-derived protectin D1 J Immunol 182 2009 3223 3232
219. P. Lipton Ischemic cell death in brain neurons Physiol Rev 79 1999 1431 1568
220. T. Nakagomi, T. Sasaki, T. Kirino, A. Tamura, M. Noguchi, and I. Saito Effect of cyclooxygenase and lipoxygenase inhibitors on delayed neuronal death in the gerbil hippocampus Stroke 20 1989 925 929
221. K. van Leyen, H.Y. Kim, S.R. Lee, G. Jin, K. Arai, and E.H. Lo Baicalein and 12/15-lipoxygenase in the ischemic brain Stroke 37 2006 3014 3018
222. P.A. Lapchak, P. Maher, D. Schubert, and J.A. Zivin Baicalein, an antioxidant 12/15-lipoxygenase inhibitor improves clinical rating scores following multiple infarct embolic strokes Neuroscience 150 2007 585 591
223. Y. Zhang, H. Wang, J. Li, D.A. Jimenez, E.S. Levitan, and E. Aizenman Peroxynitrite-induced neuronal apoptosis is mediated by intracellular zinc release and 12-lipoxygenase activation J Neurosci 24 2004 10616 10627
224. S. Pallast, K. Arai, A. Pekcec, K. Yigitkanli, Z. Yu, and X. Wang Increased nuclear apoptosis-inducing factor after transient focal ischemia: a 12/15-lipoxygenase-dependent organelle damage pathway J Cereb Blood Flow Metab 30 2010 1157 1167
225. S.P. Cregan, V.L. Dawson, and R.S. Slack Role of AIF in caspase-dependent and caspase-independent cell death Oncogene 23 2004 2785 2796
226. G. Jin, K. Arai, Y. Murata, S. Wang, M.F. Stins, and E.H. Lo Protecting against cerebrovascular injury: contributions of 12/15-lipoxygenase to edema formation after transient focal ischemia Stroke 39 2008 2538 2543
227. A. Lebeau, F. Terro, W. Rostene, and D. Pelaprat Blockade of 12-lipoxygenase expression protects cortical neurons from apoptosis induced by beta-amyloid peptide Cell Death Differ 11 2004 875 884
228. Y. Yao, C.M. Clark, J.Q. Trojanowski, V.M. Lee, and D. Pratico Elevation of 12/15 lipoxygenase products in AD and mild cognitive impairment Ann Neurol 58 2005 623 626
229. Yang H, Zhuo JM, Chu J, Chinnici C, Pratico D. Amelioration of the Alzheimer's disease phenotype by absence of 12/15-lipoxygenase. Biol Psychiatry, 2010.
230. Y. Li, P. Maher, and D. Schubert A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion Neuron 19 1997 453 463 (Pubitemid 27374242)
231. S. Canals, M.J. Casarejos, S. de Bernardo, E. Rodriguez-Martin, and M.A. Mena Glutathione depletion switches nitric oxide neurotrophic effects to cell death in midbrain cultures: implications for Parkinson's disease J Neurochem 79 2001 1183 1195
232. Rai G, Kenyon V, Jadhav A, Schultz L, Armstrong M, Jameson JB, et al. Discovery of potent and selective inhibitors of human reticulocyte 15-lipoxygenase-1. J Med Chem 2010.